Millions in malaria drugs stolen

Apr 21, 2011 By MARIA CHENG , AP Medical Writer
Dr. Esther Dalizu holds a pack of Coartem Malaria drugs in a pharmacy in Nairobi, Kenya, Wednesday, April 20, 2011. The drugs are manufactured in USA and is sold in Kenya at shilling 60 for 24 tablets. ( about 40 US cents). A leading global health fund has concluded millions of dollars worth of its donated malaria drugs have been stolen in recent years, vastly exceeding earlier findings on such thefts, according to confidential documents obtained by The Associated Press (AP Photo/Sayyid Azim)

(AP) -- A global health fund believes millions of dollars worth of its donated malaria drugs have been stolen in recent years, vastly exceeding the levels of theft previously suspected, according to confidential documents obtained by The Associated Press.

The internal investigation by the to Fight AIDS, Tuberculosis and Malaria comes two months into a new anti-corruption program that the fund launched after an AP report detailing fraud in their grants attracted intense scrutiny from donors.

In internal documents detailing drug thefts, officials identified 13 countries, mostly in Africa, where millions of dollars worth of malaria drugs have gone missing. According to the reports, drug theft in which donated drugs are sold on the black market "appears to be on the rise and (is) becoming increasingly sophisticated."

The reports were provided to the AP by an official with a different health organization, who did so on condition of anonymity because he was granted confidential access to the documents by a Global Fund staffer.

Global Fund spokesman Jon Liden confirmed the fund suspects $2.5 million worth of malaria drugs were stolen from Togo, Tanzania, Sierra Leone, Swaziland and Cambodia, dating mainly from 2009 to 2011, but with some cases going further back. He said investigations are under way to determine how much more was stolen elsewhere.

"We take this very seriously and we will do what it takes to protect our investment," he said.

An AP report in January exposed high rates of misappropriated money in some Global Fund grants and bruised the reputation of the multibillion-dollar fund, backed by big names including Bono and Bill Gates and hailed as an alternative to the bureaucracy of the United Nations.

But the fact that these revelations have come to light at all may be due to stricter self-policing and greater transparency at the Global Fund, compared with other aid organizations.

Malaria infects more than 250 million people every year, killing about 1 million, the vast majority of whom are children in Africa. Because there is a huge demand for malaria drugs, which are widely available at pharmacies and on private markets, they are easier to sell than drugs for other diseases like AIDS, which are mainly handed out at health clinics.

After discovering the scope of the malaria drug thefts, the new Global Fund documents indicate the fund took prompt action, suspending grants for medicines to be stored at government warehouses in Swaziland and Malawi.

Other than the drugs confirmed stolen in Togo, Tanzania, Sierra Leone, Swaziland and Cambodia, specific dollar figures were not available for the other nine countries, all in Africa and including Nigeria and Kenya, where the Global Fund has large programs.

The fund singled out a $200 million contract for malaria drugs in Tanzania in which it suspects theft took place. It listed the theft at more than $1 million but said "the potential cost of the misappropriation is not yet quantified." In Togo, the fund reported $850,000 worth of drugs disappeared in 2008 in a case of "insider stealing."

The audits that the AP wrote about in January suggested that tens of thousands of dollars worth of malaria drugs are stolen every year.

The Global Fund's inspector general said in a report to its board of directors late last year that it was beginning to investigate allegations of "organized theft of anti-malarial drugs" in African countries, after discovering that drugs were ending up on store shelves in African countries instead of going to the intended recipients for free.

The new documents obtained by the AP - which are the results of that investigation - show that in about 70 percent of cases, the drugs were stolen at government-operated warehouses by security personnel, warehouse managers and doctors.

"The cases show that drug misappropriations are well-organized and predominantly planned by insiders using falsified documents," one of the reports said. The documents also state that pilfered drugs are being shipped to other countries for resale, often within hours of their arrival.

Officials wrote there is a "parallel market for the sale of Global Fund-procured drugs" and that many other investigations on alleged thefts in other countries are under way.

Liden said cutting African governments from the medicine supply chain isn't realistic and that setting up independent distribution systems would be too expensive.

"We thoroughly reject the idea that we need to simply clamp down on drugs being sent to poor countries," he said. "That will cost lives."

After the U.S. government discovered evidence that its malaria drugs were disappearing in Angola and Malawi several years ago, it stopped using local government warehouses and set up entirely separate systems to give out U.S. medicines. The Global Fund has occasionally set up separate distribution systems on a temporary basis in Angola and Malawi.

Some experts say the Global Fund's drug distribution system needs to be overhauled.

"If drugs are sitting in a warehouse just waiting to be pilfered, we need to figure out a different way to make sure the people who really need them actually get them," said David Sullivan, a malaria expert at the Johns Hopkins Bloomberg School of Public Health in Baltimore.

Many health officials aren't surprised that malaria drugs are being targeted by criminals, and say no donor agency is immune.

"It's an unfortunate reality that when staff are poorly paid and systems under-resourced, the temptation of selling drugs for money will always be there," said Nathan Ford, a medical coordinator for Doctors Without Borders.

Explore further: Analgesics prescribed more heavily to women than to men, study finds

More information: http://www.theglobalfund.org

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Global Fund announces new anti-corruption measures

Feb 04, 2011

(AP) -- A $21.7 billion global health fund and the U.N.'s main development arm launched new anti-corruption measures Friday in the wake of intense scrutiny from donors and stories by The Associated Press detailing fraud ...

Malaria top killer in Congo

Apr 30, 2008

Health officials in the Democratic Republic of Congo say malaria is the primary cause of illness and death, despite prevention efforts.

Global Fund seeks cash to fight AIDS, TB, malaria

Mar 24, 2010

(AP) -- A global group funding the battle against AIDS, malaria and tuberculosis in impoverished nations worldwide is urging donors to keep paying for the fight even as the economic crisis forces budget cuts.

Germany suspends payments to global health fund

Jan 26, 2011

(AP) -- Germany says it will halt all payments to a $21.7 billion global health fund until it gets answers about serious corruption allegations raised in articles by The Associated Press.

New fund promises low-cost malaria treatment

Apr 19, 2009

(AP) -- A $225 million fund to provide low-price anti-malaria medicine around the world was launched in the Norwegian capital Friday to fight a disease that kills 2,000 children a day.

Medical aid group raises alarm about AIDS funding

Nov 05, 2009

(AP) -- The global recession and pressure to divert funds to other health crises are hurting the fight against AIDS, a medical group warned Thursday, with one health worker saying he feared a return to the days when the ...

Recommended for you

New sleeping pill poised to hit US markets

5 hours ago

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Global recommendations on child medicine

6 hours ago

Transparent information on the evidence supporting global recommendations on paediatric medicines should be easily accessible in order to help policy makers decides on what drugs to include in their national drug lists, according ...

FDA has safety concerns on Merck insomnia drug

May 20, 2013

Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.

US adviser on board of firm that sold anthrax drug

May 20, 2013

(AP)—Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while ...

User comments : 0

More news stories

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

New method for producing clean hydrogen

Duke University engineers have developed a novel method for producing clean hydrogen, which could prove essential to weaning society off of fossil fuels and their environmental implications.